Cancer prevention from the perspective of global cancer burden patterns.

Cancer is the second leading cause of death worldwide behind cardiovascular disease (1). According to the Global Burden of Disease (GBD) 2015 Study, which was conducted as part of a comprehensive regional and global research program assessing the mortality and disability caused by major diseases, injuries, and risk factors and involving over 500 researchers representing over 300 institutions and 50 countries, cancer mortality decreased between 2005 and 2015 despite the global incidence rates of cancer increasing during this period (1).

[1]  Paolo Vineis,et al.  Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  F. Collins,et al.  Aiming High--Changing the Trajectory for Cancer. , 2016, The New England journal of medicine.

[3]  P. Vineis,et al.  Global cancer patterns: causes and prevention , 2014, The Lancet.

[4]  G. Colditz,et al.  Physical activity and colon cancer prevention: a meta-analysis , 2009, British Journal of Cancer.

[5]  Y. Goto,et al.  Causal role of Helicobacter pylori infection in gastric cancer. , 2006, World journal of gastroenterology.

[6]  R. Warnke,et al.  Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[7]  C. Friedenreich,et al.  Physical activity and cancer prevention: from observational to intervention research. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  M. Mondelli,et al.  Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen‐year prospective cohort study , 2007, Hepatology.

[9]  Anders Engeland,et al.  Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. , 2003, Journal of the National Cancer Institute.

[10]  Sergio L. Schmukler,et al.  Emerging Market Instability : Do Sovereign Ratings Affect Country Risk and Stock Returns ? , 1997 .

[11]  F. Bazzoli,et al.  Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer? , 2009, Annals of Internal Medicine.

[12]  B. Kramer,et al.  Tobacco addiction: implications for treatment and cancer prevention. , 1997, Journal of the National Cancer Institute.

[13]  J. Ertle,et al.  Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis , 2011, International journal of cancer.

[14]  友孝 祖父江.  National Lung Screening Trialの概要と評価 , 2012 .

[15]  Zong-tang Sun,et al.  Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial , 2014, PLoS medicine.

[16]  H. Jessen,et al.  HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. , 2011, The New England journal of medicine.

[17]  H. Morgenstern,et al.  Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. , 2010, International journal of epidemiology.

[18]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[19]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[20]  Emily White,et al.  Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) , 2002, Cancer Causes & Control.

[21]  F. Wiklund,et al.  Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. , 1999, The New England journal of medicine.

[22]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[23]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[24]  C. Wheeler,et al.  Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.